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ABSTRACT. This study describes the cloning of the gene encoding a novel 
phenylalanine ammonia-lyase from Kangiella koreensis (KkPAL) into pET19b 
expression vector. Optimization of protein expression and purification 
conditions yielded 15 mg pure soluble protein from one liter of E. coli culture. 
Enzymatic activity measurements of the ammonia elimination reaction from 
different natural aromatic amino acids proved the protein to be a phenylalanine 
ammonia-lyase. The isolated protein showed remarkably high, 81.7 °C melting 
temperature, making it especially suitable for biocatalytic applications.  
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INTRODUCTION 
 
The use of enzymes as biocatalysts for the preparation of chemicals 
has received steadily increasing attention over the past few years and 
found significant applications in many areas, especially in the synthesis of 
                                                
a Babeş-Bolyai University, Faculty of Chemistry and Chemical Engineering, Arany János str. 11, 
RO-400028, Cluj-Napoca, Romania. 
b Department of Organic Chemistry and Technology, Budapest University of Technology and 
Economics, Műegyetem rkp. 3, H-1111 Budapest, Hungary. 
c Department of Biotechnology and Food Sciences, Budapest University of Technology and 
Economics, Szt. Gellért tér 4, H-1111 Budapest, Hungary. 
d Institute of Enzymology, Research Centre for Natural Sciences of Hungarian Academy of 
Sciences, Magyar tudósok körútja 2, H-1117 Budapest, Hungary. 
e Clinical, Pharmacology and Pharmacokinetics Department, Terapia SA, Fabricii str. 124, 
RO-400632 Cluj-Napoca, Romania. 
* Corresponding authors: cslbencze@chem.ubbcluj.ro; poppe@mail.bme.hu; 
A. VARGA, Z. BATA, P. CSUKA, D. M. BORDEA, B. G. VÉRTESSY, A. MARCOVICI, F. D. IRIMIE, 
L. POPPE, L. C. BENCZE 
 
 
294 
pharmaceutical and fine chemical targets. [1] Microbial sources received 
significant attention in the development of enzymes for research or 
industrial purposes, as microbes can be produced economically in short 
fermentation time and using inexpensive media. [2]  
 The natural role of phenylalanine ammonia-lyases (PALs) is the 
catalysis of non-oxidative ammonia elimination from L-phenylalanine (L-
Phe), to form (E)-cinnamic acid,[3] as part of the phenylpropanoid synthesis 
pathway in case of plants, and to form secondary metabolites in fungi and 
bacteria. [4] Structurally, PALs resemble to phenylalanine 2,3-aminomutases 
(PAMs),[5] tyrosine 2,3-aminomutases (TAMs),[6] tyrosine ammonia-lyases 
(TALs),[7] and histidine ammonia-lyases (HALs). [8] All of these enzymes 
rely on the protein-derived electrophilic prosthetic group, 3,5-dihydro-4-
methylidene-5H-imidazol-5-one (MIO), that forms autocatalytically from an 
XSG triade which contains usually Ala-Ser-Gly active site residues. [9]  
 Synthetic applications are based mostly on the reverse reaction of 
PAL, as the stereoselective ammonia addition results in the formation of 
enantiopure unnatural L-amino acids from the corresponding arylacrylates. 
[10] However, PALs as biocatalysts in these reactions must withstand as 
high as 6M ammonia concentrations to achieve high conversions. PALs of 
marine origin – especially PAL from Idomarina loihiensis (IlPAL) – were 
capable of catalyzing the ammonia addition with high activity at elevated 
ammonia and substrate concentrations. [11] Alternatively, enzyme 
immobilization proved to be a successful strategy for prolonging the lifetime 
of PALs as biocatalysts. [12] 
 In frame of our general interest to clone thermotolerant and stable 
PALs as efficient biocatalysts focusing on enzymes of marine and 
extremophile origin, herein we describe the molecular cloning, expression 
and purification of a novel PAL from a marine bacterium Kangiella 
koreensis (KkPAL). [13]  
 
 
RESULTS AND DISCUSSION 
 
Identification of KkPAL 
 
Prokaryotic MIO enzymes are about 150-200 residues shorter 
than the MIO enzymes from eukaryotes, as the eukaryotic ones contain 
an additional shielding domain at their C-terminus (Table 1). The 
shorter bacterial enzymes tend to be more stable than the ones of 
eukaryotic origin. 
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Table 1. Comparison of six typical MIO enzymes. 
 
 Uniprot code Seq. length Seq. identity [14] 
Kangiella koreensis PAL 
Idomarina loihiensis PAL 
Anabaena variabilis PAL 
Petroselinum crispum PAL 
Rhodobacter sphaeroides TAL 
Pseudomonas putida HAL 
C7R9W9 
Q5QXE5 
Q3M5Z3 
P24481 
Q3IWB0 
P21310 
516 
515 
567 
716 
523 
510 
100% 
66% 
28% 
22% 
29% 
27% 
 
 
 Proteins encoded in extremophile organisms, similarly to their host 
organisms, are adopted to their living conditions. Thus, enzymes isolated 
from thermophilic or marine organisms are expected to function efficiently 
at high temperatures and salt concentrations, respectively. A recently 
identified PAL from Idomarina loihiensis (IlPAL) [15] showed promising 
results in the production of optically active phenylalanine derivatives. [11] A 
bioinformatics based search using Blastp in the NCBI Non-redundant 
protein sequence database identified the KkPAL sequence to be 66% 
identical to IlPAL (Table 1). Thus, it was expected that KkPAL could be a 
stable and efficient biocatalyst for the synthesis of optically active 
phenylalanine analogues.  
 Comparison of the active site residues of KkPAL with IlPAL and two 
further MIO enzymes (Table 2) showed that all catalytic residues and residues 
in the carboxylate binding region of the active site were conserved. However, 
the aromatic binding region of the active site of KkPAL appeared to be 
different, as at position 90 in KkPAL, a histidine was found instead of 
leucine within the mesophilic PALs (AvPAL and PcPAL). Automated 
annotation of the sequence database assigned HAL function to the KkPAL 
sequence due to the characteristic histidine residue at position 90. 
However, phenylalanine at position 89 renders the aromatic binding pocket 
of the active site more “PAL-like” (Table 2). Based on sequence similarity, 
we hypothesized that amongst the natural aromatic amino acids, this 
enzyme will be the most active in the ammonia elimination reaction from 
phenylalanine. 
Histidine to phenylalanine mutations of the adjacent residue 
(residue 89 in Table 2.) enhanced the PAL activity of the tyrosine 
ammonia-lyase from Rhodobacter sphaeroides (RsTAL), and decreased 
significantly the TAL activity. [16] The presence of a hydrogen bond forming 
residue, histidine at the aromatic binding pocket of KkPAL suggested a 
possible tyrosine ammonia-lyase activity and probable substrate 
promiscuity towards other natural aromatic amino acids.  
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Table 2. Sequence alignment of active site residuesa in six typical MIO enzymes 
 
  a Active sites residues are colored by their locations and roles. Residues directly involved in 
catalysis are shown in green. Residues forming the hydrophobic binding pocket (binding of 
the aromatic group) are shown in orange and residues found at the hydrophilic part 
(carboxylate binding) of the binding pocket are shown in blue. 
 
Molecular cloning of KkPAL 
 
 The gene encoding KkPAL was codon optimized for better 
expression in E. coli and synthesized. The synthetic KkPAL gene was 
cloned in pUC57 production vector and later sub-cloned into the pET19b 
expression vector. Restriction sites for NdeI, NcoI and BamHI were added 
to the protein coding sequence allowing directional cloning into the 
expression vector. Primers detailed in Table 3 (KkPAL_forward and 
KkPAL_reverse primers) were used to amplify the synthetic gene from the 
pUC57 cloning vector, followed by restriction cloning to the expression 
vector using NdeI and BamHI enzymes and T4 DNA ligase. The pET19b 
vector contains an N-terminal His10-tag attached through enterokinase 
cleavage site to the inserted sequence, facilitating protein purification. 
 
Table 3. Primers used for amplification of KkPAL gene and for the colony PCR 
 
Primers Sequences Tm (°C) 
KkPAL_forward primer 5’CTAGATAATACCATGGGCCATATG3’ 62 
KkPAL_reverse primer 5’CCGATTATGGATCCTTAGTTAGC3’ 62 
T7-promoter_forward primer 5’AATACGACTCACTATAGGGGAATTG3’ 54 
T7-terminator_reverse primer 5’TGCTAGTTATTGCTCAGCGG3’ 55 
 
Colony PCR verified the successful insertion of the DNA encoding 
KkPAL to the pET19b vector. This convenient high-throughput method 
determines the presence or absence of the inserted DNA sequence by a 
standard PCR process, from individual colonies obtained after the ligation 
reaction. Vector specific T7-promoter forward and T7-terminator reverse 
oligonucleotides (Table 3) served as primers for the PCR reactions. 
Sequencing of plasmid DNA, isolated from the colonies with positive colony 
PCR reactions, ascertained the cloning results.  
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Optimization of the overexpression of KkPAL 
 
Variation of the host cell strain, growth temperature and inducer 
concentration influence the overexpression levels of the target protein. 
Strategy for optimization and the identified optimal conditions for KkPAL 
overexpression are detailed in the next section.  
E. coli is the most commonly used bacterial host for recombinant 
protein production. It has become the most popular expression platform, as 
it is easy to manipulate genetically, inexpensive to culture, and its 
expression is rapid. [17] E. coli strain Rosetta(DE3)pLysS enables low 
background expression, and expresses T7 lysozyme suppressing basal T7 
RNA polymerase expression, reducing translation of the pET recombinants 
in the absence of inducer. Hence, we choose Rosetta(DE3)pLysS as host 
strain for expression of KkPAL. 
 
Optimization of the inducer concentration 
 
Induction of the lac promoter expresses the target genes in pET 
systems. Naturally, this promoter is induced by the lactose metabolite 
allolactose. However, in practice the non-degradable IPTG (isopropyl β-D-
1-thiogalactopyranoside) is employed, instead of lactose. Varying the 
concentration of IPTG regulates the expression of the target protein. 
Lowering the IPTG concentration may reduce the protein expression level, 
thereby increasing the solubility of aggregation prone protein. Although at 
the cost of increased expression time and lower protein yield. [18]  
Protein expression levels of recombinant KkPAL as a function of 
various inducer concentrations were evaluated in liquid cultures. Upon 
achieving exponential growth phase (OD at 600 nm ~ 0.6), cultures were 
induced with five different concentrations of IPTG between 0 mM and 0.5 
mM and expression proceeded for 3 h at 37 °C (Figure 1). KkPAL 
expression occurred already at 0.1 mM IPTG (60 kDa band Lane 3), and 
inducer concentration above 0.1 mM enhanced KkPAL production (Lanes 
4-6). However, further increase of the IPTG concentration above 0.2 mM 
(Lane 4) did not increase KkPAL expression (Lanes 5,6). As later 
experiments showed, the protein expressed in a soluble form, therefore the 
IPTG concentration was set to 0.2 mM. 
 
Effect of expression temperature on the overexpression of KkPAL 
 
The optimum temperature for E. coli growth is 37 °C, and several 
studies reported 37 °C as the best temperature for maximum protein 
production as well. [19] On the other hand, other studies showed that not 
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only the rate of expression, but the culturing temperature affects the proper 
folding of recombinant proteins. [20] Lowering the expression temperature 
leads to slower growth of bacteria and reduces the rate of protein 
production, hence decreasing the risk of aggregation of target protein. In 
addition, most of the proteases express much less activity at lower 
temperatures. Thus, degradation of the target proteins at lower 
temperatures are much less pronounced. [21,22] 
 
 
 
Figure 1. SDS-PAGE showing the effect of various IPTG concentrations on the 
expression of KkPAL (after 4 h at 37 °C). Samples in the lanes: 1: protein ladder, 2: 
control (0 mM IPTG), 3: induction with 0.1 mM IPTG, 4: induction with 0.2 mM 
IPTG, 5: induction with 0.3 mM IPTG, 6: induction with 0.5 mM IPTG. 
 
Intermittent optical densitometry (OD) measurements at 600 nm 
evaluated the effect of growth temperature on the expression of KkPAL after 
induction. Initially, the cell cultures were incubated at 37 °C. After the density of 
cells reached OD600 ~ 0.4 (approx. 2-3 h), the temperature was reduced (to 20, 
25 or 30 °C). To allow cultures to adjust to the temperature change, protein 
production was only induced 30 minutes after decreasing the temperatures. 
The density of the cells was monitored as a function of time (Figure 2).  
Due to the reduced incubation temperature, the protein synthesis 
rate was slower at 20 °C than at 25 or 30 °C and longer induction times 
were necessary for cells growth. At higher expression temperatures (25 or 
30 °C), the protein synthesis was faster and the stationary phase was 
reached after 8 h, compared to 14 h at 20 °C. After post-induction, the cells 
were harvested by centrifugation, followed by sonication and the crude 
protein mixture in the lysate was purified by metal affinity chromatography 
on Ni-NTA resin. The maximum yield, 15 mg L-1 purified enzyme, was 
obtained at 25 °C expression temperature. The optimal post-induction time 
on the expression of KkPAL was 12-14 h. 
KkPAL 
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Figure 2. Growth curves of E. coli Rosetta(DE3)pLysS containing the pET19b-
KkPAL plasmid, at 20, 25 and 30 °C in LB medium. 
 
 
Purification 
 
Purification using Ni-NTA chromatography 
 
Ni–NTA chromatography is a rapid and easy purification technique 
for recombinant proteins carrying a His-tag at either the N- or C-terminus. 
The N atoms of the imidazole rings of the His-tag residues form complexes 
with the unoccupied coordination sites of the immobilized nickel ions. [23]  
In the pET19b vector, a His10-tag at the N-terminus is fused to the 
target proteins, which is longer than the usual His6-tag. Lengthening the 
His-tag increases the affinity of the enzyme to the Ni-NTA resin. 
Consequently, higher imidazole concentrations were required to elute the 
bounded enzyme from the resin (from 250 mM up to 500 mM). [24] We 
observed, that KkPAL activity decreased after elution from the Ni-NTA 
column probably due to prolonged exposure to high imidazole 
concentration. In order to eliminate this effect, we tested 250, 350, 450, 500 
mM imidazole concentrations for protein elution. The best result was 
obtained by elution with 350 mM imidazole, resulting in a protein solution 
which gave a single band on the SDS-PAGE (Figure 3, Lane 2), indicating 
high purity of the target enzyme.  
 
A. VARGA, Z. BATA, P. CSUKA, D. M. BORDEA, B. G. VÉRTESSY, A. MARCOVICI, F. D. IRIMIE, 
L. POPPE, L. C. BENCZE 
 
 
300 
 
 
Figure 3. Purification of KkPAL with Ni-NTA chromatography. Lane 1: protein ladder, 
Lane 2: fraction eluted from Ni-NTA with 350 mM imidazole. Samples were 
prepared as described in the experimental section. 
 
Characterization of KkPAL 
 
Enzyme activity measurements 
 
PAL activity was assayed both in the ammonia elimination and in the 
ammonia addition reactions. The enzyme activity in the ammonia elimination 
reaction was determined spectrophotometrically by monitoring the formation of 
(E)-cinnamic acid. Conversions after 16 h obtained by HPLC analysis 
characterize the enzyme activity in the ammonia addition reaction. [25] In 
Table 4 the specific activity and the conversion of the reaction catalyzed by 
KkPAL were compared with the corresponding properties of the well-studied 
PcPAL. Contrary to our expectations, PcPAL had better catalytic activity in the 
addition as well as in the elimination reactions.  
 
Table 4. Specific activities in the ammonia elimination and the conversion in the 
addition reactions measured for KkPAL and PcPAL. 
 
Enzyme 
Elimination reaction Addition reaction 
Specific activity a
[µmol min-1 mg-1] 
Conversion b 
[%] 
KkPAL 0.063 3.9 
PcPAL 1.08 77.2 
a Specific activity measured at 30 °C, with 5 mM L-phenylalanie at pH 8.5 in 100 mM TRIS buffer. 
b Conversion measured after 16 h at 30°C, with 5 mM (E)-cinnamic acid and 6 M ammonium-
carbonate, pH 10. 
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KkPAL catalyzed ammonia elimination also from L-tyrosine, however at 
a slower rate compared to phenylalanine. The spectrophotometric assays 
could not detect ammonia elimination from histidine and tryptophan, 
corroborating with the sequence based annotation of the protein as 
phenylalanine ammonia-lyase.  
 
Thermal stability 
 
 The nanoDSF differential scanning fluorimetry technique is able to 
analyze the conformational stability and colloidal stability (aggregation 
behavior) of proteins under different thermal and chemical conditions. 
The conformational stability of a protein is described by the unfolding 
transition midpoint Tm (°C), which is the point at which half of the protein is 
unfolded. The truly label-free nanoDSF method monitors the intrinsic 
fluorescence of tryptophans in proteins, which relies on the close 
surrounding of the given tryptophan and changes upon thermal unfolding. 
Maximum values in the change of the first derivate of the fluorescent signal 
define the melting temperature of the protein. 
 
 
 
Figure 4. Thermal unfolding curve of KkPAL obtained by nanoDSF measurement 
 
 
The KkPAL exhibited outstanding thermal stability, as its melting 
temperature was 81.7 °C (Figure 4). This melting temperature is 10 °C 
higher than that of the eukaryotic PcPAL, 71 °C.  
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CONCLUSIONS 
 
Different experimental conditions were examined for the expression 
and purification of KkPAL in order to obtain the enzyme in high yield and 
high purity. After optimization of IPTG concentration, post-induction 
temperature on the expression and the imidazole concentration in the 
purification steps, 15 mg L-1 of high purity protein was obtained. For 
production of KkPAL the induction level with an IPTG concentration of 0.2 
mM was sufficient, followed by 12-14 h post-induction incubation at 25 °C. 
During the purification of the His10-tagged protein on Ni-NTA column, a 
reduction of the imidazole concentration from 500 mM to 350 mM improved 
the stability of the resulted enzyme.  
Activity measurements showed that the newly cloned KkPAL was 
less active in the ammonia elimination and addition reactions than the 
most frequently used PcPAL, but the melting temperature of this novel 
PAL from a marine bacterium exceeded that of the eukaryotic protein by 
about 10 C. 
The hydrophobic binding pocket KkPAL, similarly to IlPAL is a 
hybrid between the typical motifs found in TALs and HALs. In agreement 
with our sequence-based annotation, KkPAL showed the highest activity 
towards phenylalanine amongst the aromatic amino acids. Nevertheless, 
residue patterns at the hydrophobic region of the binding pocket and the 
recently reported F137V PcPAL with expanded substrate range,[26] 
suggest that site directed mutagenesis could enhance activity towards 
other aromatic amino acids.  
 
 
EXPERIMENTAL SECTION 
 
All reagents were purchased from Sigma-Aldrich, unless otherwise 
specified.  
 
Synthesis and cloning of KkPAL gene 
 
The gene of the Kangiella koreensis PAL (Uniprot code: C7R9W9, 
encoding 735 AA – Table 5) was optimized to the codone usage of E. coli. 
The 1538 bp long synthetic gene was produced by Genscript in pUC57 
vector. At the end of the gene, restriction sites of NdeI, NcoI and BamHI 
restriction enzymes were introduced for directional cloning into the pET19b 
expression vector (Figure 5).  
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Table 5. Amino acid and DNA sequences of recombinant wt-KkPAL 
 
 
 
 
 
 
Figure 5. Vector map of the pET19b-KkPAL construct.  
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PCR reaction for amplification of the gene  
 
The PCR reactions with a total volume of 50 μL consisted of 90 ng 
of DNA template (plasmid containing the gene of KkPAL), 1 μM of each of 
the primers, 200 μM dNTP (ThermoFischer) and 2.5 units of Phu Hot-Start 
DNA polymerase (ThermoFischer). The PCR cycles were initiated at 95 °C 
for 3 min to denature the template DNA, followed by 35 amplification cycles 
(95 °C for 30 s, 57 °C for 30 s and 72 °C for 3 min). The PCR cycles were 
finished with a final extension step at 72 °C for 15 min.  
The PCR products were further purified, using the DNA Clean & 
Concentrator™-25 Kit, by Zymo research. The purified PCR products and 
the recipient circular pET19b vector were digested with NdeI and BamHI 
restriction enzymes (ThermoFischer), at 37 °C for 1 h and then 40 μL 
(approx. 2 µg) of each digested DNA was purified by agarose gel 
electrophoresis. The DNA bands were cut out from the agarose gel. The 
recipient plasmid and insert at a molar ratio 1:3 were co-extracted using 
Gen Elute Gel Extraction Kit (Genomed) and afterwards ligated in presence 
of T4 DNA ligase (ThermoFischer) at 22 °C for 1 h.   
 
Transformation in E. coli cells 
 
 For the transformation of plasmid DNA into E. coli XL1-Blue (for 
plasmid amplification) and Rosetta(DE3)pLysS (for expression) the heat 
shock method was used. Thawing the chemically competent bacterial 
cells (50 µL) on ice for 15 min, 1-2 µL of plasmid DNA was added followed 
by incubation for 20 min on ice. The heat shock was performed by 
incubating the sample at 42°C for 45 s, and on ice for further 2 min. 400 
µL LB media was added and the cells were grown at 37 C for 1 h. In case 
of XL1-Blue transformation the transformed bacteria were plated on LB 
agar-plates containing tetracycline (30 μg mL-1) and carbenicilin (50 μg 
mL-1). In case of Rosetta(DE3)pLysS transformation carbenicillin (50 µg 
mL-1) and chloramphenicol (30 µg mL-1) were used. pET19b encodes the 
resistance gene for ampicillin, however carbenicillin was used for 
selection, due to its higher stability. Agar plates were incubated overnight 
at 37°C, forming single colonies of bacteria bearing the plasmid encoding 
the recombinant protein.  
 
Colony PCR reaction 
 
The PCR reactions with a total volume of 20 μL consisted of 10 μL 
Dream Tag Green Master Mix (ThermoFischer), 1 μM each of the primers 
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(Table 3), one colony of DNA template and 8 μL of ddH2O. The PCR cycles 
were initiated at 95°C for 3 min to denature the template DNA, followed 
by 40 amplification cycles. Each amplification cycle consisted of 95°C for 
3 min, 57°C for 30 s and 72 C for 1 min 30 sec. The PCR cycles were 
finished with a final extension step at 72°C for 15 min. The PCR 
reactions were analyzed by agarose gel electrophoresis. Presence of 
the amplified ~1500 bp product indicated colonies where insertion of the 
gene was successful.  
 
Expression of the recombinant KkPAL 
 
The recombinant KkPAL carrying N-terminal (His)10-tag was 
overexpressed in E. coli host cells Rosetta(DE3)pLysS. For the expression 
step, a colony of the transformed plasmid was grown overnight at 37°C in 
50 mL of Luria-Bertani (LB) medium containing carbenicillin (50 µg mL-1) 
and chloramphenicol (30 µg mL-1). A 0.5 L of LB medium was inoculated 
with 1 v/v% of the overnight culture and grown at 37°C until the optical 
density at 600 nm (OD600) reached 0.4, after which the temperature was 
reduced to 20, 25 and 30°C. To induce protein production varying 
concentrations of IPTG was added to the cells at OD600 of 0.6-0.7. In the 
expression phase the culture was shaken at 180 rpm for 16 h.  
 
Purification of KkPAL 
 
All protein purification steps were performed at 4 C. Cells were 
harvested by centrifugation (25 min, 5000×g) and resuspended in 50 mL 
lysis buffer (150 mM NaCl, 50 mM TRIS (2-amino-2-(hydroxymethyl)propane-
1,3-diol) pH 7.5) supplemented with DNAse, RNAse, Lysosyme and EDTA-
free protease-inhibitor cocktail. Further, the cells were lysed by sonication 
and cell debris was removed by centrifugation (12000×g, 30 min).  
The His-tagged KkPAL was separated from other proteins in the 
supernatant by Ni-NTA-agarose column. After loading the sample, the 
column was washed with low salt buffer, (50 mM HEPES (4-(2-
hydroxyethyl)piperazine-1-ethanesulfonic acid), 30 mM KCl pH 7.5 4V; V= 
resin volume) high salt buffer (50 mM HEPES, 300 mM KCl pH 7.5, 2V), 
and low salt buffer (2-4V) again. The low salt buffer supplemented with 25 
mM imidazole removed the non-specifically bound contaminating proteins. 
Low salt buffer supplemented with varying amounts (between 250-500 mM) 
imidazole eluted the KkPAL from the column. 
The resulting eluate was dialyzed against 100 mM TRIS-buffer (pH 
8.0) for 5 h at 4 C. The purity of the resulting fractions was verified by SDS-
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PAGE analysis on a 12% SDS-PAGE. After dialysis the fractions containing 
purified protein were concentrated by centrifugal ultrafiltration with Amicon 
filter units. The concentration of the purified protein was determined by the 
Bradford method.  
 
Enzyme activity measurements 
 
Elimination reactions. Activity of KkPAL in the ammonia elimination 
reaction was determined spectrophotometrically by monitoring the 
formation of the conjugated acrylic acid product. The measurements were 
performed at 30 C for 5 min with 5 mM L-phenylalanine, in the presence of 
0.3 µM enzyme in 0.1 M TRIS-buffer (pH 8.5). Phenylalanine ammonia-
lyase activity was determined by measuring the formation of (E)-cinnamic 
acid at 290 nm for 10 min, using quartz cuvettes of 1 mL. Histidine 
ammonia-lyase activity was determined as the rate of urocanate formation 
measured spectrophotometrically at 277 nm. The conversion of L-tyrosine 
to p-coumarate followed at 310 nm, determined the tyrosine ammonia-lyase 
acitvity. Tryptophan ammonia-lyase activity was measured by the rate of 
indole 3-acrylic acid formation at 315 nm.  
 
Addition reactions. Into the solution of (E)-cinnamic acid (5 mM) in 6 
M NH3, pH 10 (adjusted with CO2), KkPAL or PcPAL (0.6 µM) was added 
and the reaction mixtures were shaken at 300 rpm, at 30°C. After 16 h 
samples (50 μL) were taken from the enzymatic reaction mixtures, 
quenched by adding an equal volume of MeOH, vortexed and centrifuged 
(13000 rpm, 2 min). The supernatant was filtered through a 0.22 μm 
membrane filter and used directly for HPLC analysis. 
Conversions were determined on Phenomenex Gemini NX-C-18 
column, using as mobile phase: NH4OH buffer (0.1 M, pH 8.5): MeOH 
90:10 to 61:39 in 12 min and 1 mL min-1 flow rate. Conversions were 
calculated from peak area integrations with use of appropriate response 
factors. [25] 
 
Thermal stability assay 
 
 The thermal stability of the enzyme was determined by nanoDSF. 
The capillaries were filled with the 0.125 mg mL-1 (2 µM) KkPAL in 100 mM 
TRIS-buffer pH 8.5 and placed onto the capillary tray of the Prometheus 
NT.48, NanoTemper Technologies. Melting curves were measured by 
heating the samples by 1°C min-1 increment from 20°C to 95°C.  
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